Does UPADACITINIB Cause Musculoskeletal stiffness? 1,309 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 1,309 reports of Musculoskeletal stiffness have been filed in association with UPADACITINIB (Rinvoq). This represents 2.0% of all adverse event reports for UPADACITINIB.
1,309
Reports of Musculoskeletal stiffness with UPADACITINIB
2.0%
of all UPADACITINIB reports
84
Deaths
269
Hospitalizations
How Dangerous Is Musculoskeletal stiffness From UPADACITINIB?
Of the 1,309 reports, 84 (6.4%) resulted in death, 269 (20.6%) required hospitalization, and 87 (6.6%) were considered life-threatening.
Is Musculoskeletal stiffness Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for UPADACITINIB. However, 1,309 reports have been filed with the FAERS database.
What Other Side Effects Does UPADACITINIB Cause?
Pain (4,444)
Arthralgia (3,815)
Drug ineffective (3,384)
Covid-19 (2,978)
Rheumatoid arthritis (2,730)
Pain in extremity (2,353)
Fatigue (2,153)
Fall (2,081)
Surgery (2,037)
Therapy interrupted (1,741)
What Other Drugs Cause Musculoskeletal stiffness?
ADALIMUMAB (10,762)
METHOTREXATE (9,903)
ETANERCEPT (9,744)
TOFACITINIB (7,354)
TOCILIZUMAB (6,346)
RITUXIMAB (6,058)
LEFLUNOMIDE (6,031)
ABATACEPT (5,926)
SECUKINUMAB (5,655)
HYDROXYCHLOROQUINE (5,271)
Which UPADACITINIB Alternatives Have Lower Musculoskeletal stiffness Risk?
UPADACITINIB vs URAPIDIL
UPADACITINIB vs UREA
UPADACITINIB vs URIDINE TRIACETATE
UPADACITINIB vs UROFOLLITROPIN
UPADACITINIB vs URSODIOL